Article info
PDFClinical science
Ruthenium-106 brachytherapy for iris and iridociliary melanomas
- Correspondence to Dr Marina Marinkovic, Department of Ophthalmology and Melanoma Center, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; m.marinkovic{at}lumc.nl
Citation
Ruthenium-106 brachytherapy for iris and iridociliary melanomas
Publication history
- Received May 22, 2017
- Revised October 23, 2017
- Accepted October 26, 2017
- First published November 9, 2017.
Online issue publication
September 29, 2018
Article Versions
- Previous version (29 September 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.